Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Recommendation Statement | Chronic Obstructive Pulmonary Disease | JAMA | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.170.64.36. Please contact the publisher to request reinstatement.
Audio Author Interview (21:51)
1x
0:00 / 0:00
1.
Kochanek  KD, Murphy  SL, Xu  J, Arias  E.  Mortality in the United States, 2013.  NCHS Data Brief. 2014;(178):1-8.PubMedGoogle Scholar
2.
Tilert  T, Dillon  C, Paulose-Ram  R, Hnizdo  E, Doney  B.  Estimating the US prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010.  Respir Res. 2013;14:103.PubMedGoogle ScholarCrossref
3.
Guirguis-Blake  JM, Senger  CA, Webber  EM, Mularski  R, Whitlock  EP.  Screening for Chronic Obstructive Pulmonary Disease: A Systematic Evidence Review for the US Preventive Services Task Force: Evidence Synthesis No. 130. Rockville, MD: Agency for Healthcare Research and Quality; 2016. AHRQ Publication 14-05205-EF-1.
4.
Ford  ES, Croft  JB, Mannino  DM, Wheaton  AG, Zhang  X, Giles  WH.  COPD surveillance: United States, 1999-2011.  Chest. 2013;144(1):284-305.PubMedGoogle ScholarCrossref
5.
Centers for Disease Control and Prevention (CDC).  Chronic obstructive pulmonary disease among adults: United States, 2011.  MMWR Morb Mortal Wkly Rep. 2012;61(46):938-943.PubMedGoogle Scholar
6.
Guirguis-Blake  JM, Senger  CA, Webber  EM, Mularski  RA, Whitlock  EP.  Screening for chronic obstructive pulmonary disease: evidence report and systematic review for the US Preventive Services Task Force.  JAMA. doi:10.1001/jama.2016.2654.Google Scholar
7.
Price  DB, Tinkelman  DG, Halbert  RJ,  et al.  Symptom-based questionnaire for identifying COPD in smokers.  Respiration. 2006;73(3):285-295.PubMedGoogle ScholarCrossref
8.
Price  DB, Tinkelman  DG, Nordyke  RJ, Isonaka  S, Halbert  RJ; COPD Questionnaire Study Group.  Scoring system and clinical application of COPD diagnostic questionnaires.  Chest. 2006;129(6):1531-1539.PubMedGoogle ScholarCrossref
9.
Yawn  BP, Mapel  DW, Mannino  DM,  et al; Lung Function Questionnaire Working Group.  Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction.  Int J Chron Obstruct Pulmon Dis. 2010;5:1-10.PubMedGoogle Scholar
10.
Martinez  FJ, Raczek  AE, Seifer  FD,  et al; COPD-PS Clinician Working Group.  Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS).  COPD. 2008;5(2):85-95.PubMedGoogle ScholarCrossref
11.
Parkes  G, Greenhalgh  T, Griffin  M, Dent  R.  Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial.  BMJ. 2008;336(7644):598-600.PubMedGoogle ScholarCrossref
12.
Risser  NL, Belcher  DW.  Adding spirometry, carbon monoxide, and pulmonary symptom results to smoking cessation counseling: a randomized trial.  J Gen Intern Med. 1990;5(1):16-22.PubMedGoogle ScholarCrossref
13.
Kotz  D, Wesseling  G, Huibers  MJ, van Schayck  OC.  Efficacy of confronting smokers with airflow limitation for smoking cessation.  Eur Respir J. 2009;33(4):754-762.PubMedGoogle ScholarCrossref
14.
Sippel  JM, Osborne  ML, Bjornson  W, Goldberg  B, Buist  AS.  Smoking cessation in primary care clinics.  J Gen Intern Med. 1999;14(11):670-676.PubMedGoogle ScholarCrossref
15.
McClure  JB, Ludman  EJ, Grothaus  L, Pabiniak  C, Richards  J.  Impact of a brief motivational smoking cessation intervention: the Get PHIT randomized controlled trial.  Am J Prev Med. 2009;37(2):116-123.PubMedGoogle ScholarCrossref
16.
Qaseem  A, Wilt  TJ, Weinberger  SE,  et al; American College of Physicians; American College of Chest Physicians; American Thoracic Society; European Respiratory Society.  Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.  Ann Intern Med. 2011;155(3):179-191.PubMedGoogle ScholarCrossref
17.
Chronic obstructive pulmonary disease in over 16s: NICE guidelines [CG101]. National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/cg101. Accessed July 22, 2015.
18.
Global strategy for diagnosis, management, and prevention of COPD: 2016. Global Initiative for Chronic Obstructive Lung Disease. http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html. Accessed July 22, 2015.
Special Communication
USPSTF Recommendation Statement
April 5, 2016

Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Recommendation Statement

US Preventive Services Task Force (USPSTF)
JAMA. 2016;315(13):1372-1377. doi:10.1001/jama.2016.2638
Abstract

Importance  About 14% of US adults aged 40 to 79 years have chronic obstructive pulmonary disease (COPD), and it is the third leading cause of death in the United States. Persons with severe COPD are often unable to participate in normal physical activity due to deterioration of lung function.

Objective  To update the 2008 US Preventive Services Task Force (USPSTF) recommendation on screening for COPD in asymptomatic adults.

Evidence Review  The USPSTF reviewed the evidence on whether screening for COPD in asymptomatic adults (those who do not recognize or report respiratory symptoms) improves health outcomes. The USPSTF reviewed the diagnostic accuracy of screening tools (including prescreening questionnaires and spirometry); whether screening for COPD improves the delivery and uptake of targeted preventive services, such as smoking cessation or relevant immunizations; and the possible harms of screening for and treatment of mild to moderate COPD.

Findings  Similar to 2008, the USPSTF did not find evidence that screening for COPD in asymptomatic persons improves health-related quality of life, morbidity, or mortality. The USPSTF determined that early detection of COPD, before the development of symptoms, does not alter the course of the disease or improve patient outcomes. The USPSTF concludes with moderate certainty that screening for COPD in asymptomatic persons has no net benefit.

Conclusions and Recommendation  The USPSTF recommends against screening for COPD in asymptomatic adults. (D recommendation)

×